KHN’s ‘What the Health?’: On Capitol Hill, Actions Have Consequences
Can’t see the audio player? Click here to listen on SoundCloud. The reverberations from the J...
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
GAITHERSBURG, Md., Nov. 04, 2020 (GLOBE ...
Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
VANCOUVER, British Columbia, Oct. 30, 2020 (GLOBE ...
Lilly Provides Comprehensive Update on Progress of SARS-CoV-2 Neutralizing Antibody Programs
INDIANAPOLIS, Oct. 7, 2020 /PRNewswire/ ...
FDA Approves Bausch + Lomb Alaway Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%
LAVAL, QC and DEER PARK, Ill., Sept. 25,...
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma
London UK 9 September 2020 — GlaxoSmithKline...
Immunotherapy is safe following chemoradiotherapy for women with node-positive cervical cancer
Results from the NRG Oncology phase I clinical tri...
Investigational drugs reduce risk of death from Ebola virus disease
The investigational therapeutics mAb114 and REGN-E...
